Skip to main content
. Author manuscript; available in PMC: 2020 Mar 1.
Published in final edited form as: Circ Res. 2019 Mar;124(5):769–778. doi: 10.1161/CIRCRESAHA.118.314060

TABLE 1-.

Baseline Demographics

All Patients
(n=122)
Control
(n=57)
Post Conditioning
(n=65)
P-Value
Age (Years) 59.3 ± 10.0 59.1 ± 10.1 59.4 ± 10.1 0.84
Male, (%) 102 (85.0) 47 (82.5) 55 (87.3) 0.46
Body mass index, kg/m 29.8 ± 4.5 29.9 ± 4.4 29.6 ± 4.6 0.72
Diabetes, (%) 22 (18.3) 9 (15.8) 13 (20.6) 0.49
Family history of coronary artery disease, (%) 44 (40.4) 26 (48.2) 18 (32.7) 0.10
Hypertension, (%) 64 (53.3) 28 (49.1) 36 (57.1) 0.38
Hyperlipidemia, (%) 67 (56.3) 29 (50.9) 38 (61.3) 0.25
Current smoker, (%) 44 (37.0) 22 (39.3) 22 (34.9) 0.62
History of stroke, (%) 1 (0.8) 0 (0) 1 (1.8) 0.47
Previous PCI, (%) 12 (10.3) 6 (10.7) 6 (9.8) 0.88
Use of glycoprotein IIb/IIIa inhibitor, (%) 48 (42.1) 20 (36.4) 28 (47.5) 0.23
Infarct related artery
 RCA, (%)
 LAD, (%)
 LCx/PDA/PLA, (%)
54 (46.2)
52 (44.4)
11 (9.4)
28 (50.0)
22 (39.3)
6 (10.7)
26 (42.6)
30 (49.2)
5 (8.2)
0.55
Type of stent
 BMS, (%)
 DES, (%)
6 (5.2)
110 (94.8)
5 (9.1)
50 (90.9)
1 (1.6)
60 (98.4
0.070
Thrombectomy, (%) 39 (34.5) 24 (44.4) 15 (25.4) 0.034
TIMI grade 3 post-PCI, (%) 117 (97.5) 55 (96.5) 62 (98.4) 0.50
EF (%) 49.4 ± 11.0 48.0 ± 12.3 49.7 ± 9.9 0.72
Ischemic Duration (mins) 150 (112, 217) 159 (115, 221) 145 (112, 214) 0.55
Pre Cath Vitals
 Heart Rate 73 (64, 87) 73 (63, 85) 74 (64, 93) 0.41
 Respirations 17 (15, 20) 18 (14, 20) 17 (16, 21) 0.57
 Systolic BP 137 (119, 145) 138 (119, 144) 136 (125, 146) 0.61
 Diastolic BP 83 (75, 94) 79 (74, 93) 85 (78,96) 0.33
 O2 Saturation 98 (95, 100) 97 (95, 100) 98 (95, 100) 0.89